Senior Science Editor
at Technology Networks
After obtaining a first-class honors degree in biological sciences from the University of East Anglia, Anna worked as a scientific conference producer before joining Technology Networks. As part of her role, Anna helps to coordinate coverage, working with key opinion leaders from industry and academia to produce content across all communities.
Education
Areas of Expertise
Got a Question for Anna MacDonald?
Get in touch using the contact form linked here and we'll get back to you shortly.
Published Content
Total: 345
Industry Insight
Building Agility, Compliance and Sustainability in Sample Storage
In this interview, discover how Astoriom's Integrated Stability & Sustainability Outsourcing Model addresses traditional storage challenges and enables biopharma companies to respond more nimbly to disruptions.
Article
Building a More Inclusive Future in Biotech
Technology Networks recently had the pleasure of interviewing Dr. Tyler Brown, founder, president and chair of OUTbio San Diego, to learn more about the organization’s origins, rapid growth and mission to create lasting impact.
Industry Insight
Overcoming In Vivo Delivery Challenges With Image-Guided Innovation
Dr. Tomek Czernuszewicz shares insights on the limitations of traditional delivery techniques and how Revvity is advancing in vivo imaging through AI-powered tools.
Industry Insight
How Mass Spectrometry Is Refining Vitamin D Testing
Explore the clinical impact of accurate vitamin D measurement, how the cobas® Mass Spec solution enhances diagnostic precision and the broader role of clinical mass spectrometry in advancing personalized healthcare.
Listicle
Creating Space in Science: LGBTQIA+ Voices on Belonging in Pharma
In this listicle, LGBTQIA+ scientists offer insights into how inclusion can be built into everyday lab culture, from normalizing pronoun sharing and celebrating diverse holidays to rethinking policy and representation.
Industry Insight
Unlocking the Potential of Minicircle DNA
In this interview, we explore the limitations of pDNA, the advantages of mcDNA and how NunaBio’s technology could unlock new possibilities for safer, more efficient gene therapy.
Industry Insight
Advancing QC for Complex Biologics
David Curtin discusses how the integration of MALS detectors with Empower software enhances biopharmaceutical QC, aligns with evolving regulatory demands and supports the future of complex biologic product analysis.
Industry Insight
How Is AI Shaping the Future of mRNA Therapeutics?
Learn more about how AI is advancing the mRNA drug discovery pipeline and what we can expect to see in the future in this interview with Dr. Davide De Lucrezia.
Industry Insight
Shaping the Future of Newborn Screening
Dr. Madhuri Hegde discusses Revvity's role in the Generation Study, an ambitious initiative that will sequence the genomes of 100,000 newborns.
Industry Insight
Funding Will Advance Third-Party Verified Sustainability in Science
James Connelly discusses the importance of third-party verification and how recent funding will help accelerate the development of Impact Laboratories' digital sustainability tools.
Advertisement
